Flotral

Flotral Special Precautions

alfuzosin

Manufacturer:

Sun Pharma

Distributor:

DKLL

Marketer:

Ranbaxy
Full Prescribing Info
Special Precautions
Special precautions for use: Care should be taken when alfuzosin is administered to patients who have experienced marked hypotension following administration of another alpha-1 blocker.
In patients with coronary disease, alfuzosin should not be prescribed alone. The specific coronary insufficiency treatment should be continued. If angina pectoris recurs or worsens, alfuzosin treatment should be discontinued.
Intraoperative Floppy Iris Syndrome (IFIS, a variant of small pupil syndrome) has been observed during cataract surgery in some patients on or previously treated with some alpha-1-blockers. Although the risk of this event with alfuzosin hydrochloride prolonged release tablets appears very low, ophthalmic surgeons should be informed in advance of cataract surgery of current or past use of alpha-1-blockers, as IFIS may lead to increased procedural complications. The ophthalmologists should be prepared for possible modifications to their surgical technique.
Patients must be informed that the tablets must be swallowed whole. The tablets must not be crunched, chewed, crushed or ground into a powder. Doing so could lead to inappropriate release and absorption of the medicinal product consequently causing unwanted effects which may be of early onset.
If patient has been told by the doctor of their intolerance to some sugars, contact the doctor before taking FLOTRAL.
Effects on ability to drive and use machines: There are no data available on the effect on driving vehicles. Particular caution is required when driving vehicles or using machines due to the risks of postural hypotension, vertigo, dizzy sensations, asthenia, visual disturbances, especially at the start of treatment with alfuzosin.
Use in Children: Efficacy of alfuzosin hydrochloride prolonged release tablets 10 mg has not been reported in children aged 2 to 16 years. Therefore, alfuzosin hydrochloride prolonged release tablets 10 mg are not indicated for use in pediatric population.
Use in the Elderly: Caution is recommended, particularly in the elderly.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in